Barbara Kosacz's Net Worth
Barbara Kosacz has an <strong>estimated net worth of $1.16 Million dollars</strong>. This is based on reported shares across multiple companies, which include Locust Walk Acquisition Corp., Athira Pharma, Inc., XOMA Corp, PHOENIX BIOTECH ACQUISITION CORP., and Kronos Bio, Inc..<br /><br />He also owns<strong>928,966 shares</strong> of Kronos Bio, Inc.'s Common Stock which is worth $1,151,917.84 dollars. From 2020 to 2024 Barbara Kosacz acquired a total of <strong>192,511 shares in Kronos Bio, Inc.</strong>, Barbara also disposed a total of <strong>10,676 shares of Kronos Bio, Inc.</strong> equalling $12.6 Thousand.
Estimate Recalculated Apr 16, 2024 03:39PM EST
Who is Barbara Kosacz?
SEC CIK
Barbara Kosacz's CIK is 0001763316
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XOMA Corp (XOMA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERO THERAPEUTICS HOLDINGS, INC. (PBAX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.83K |
—
|
—
| 5.83K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Athira Pharma, Inc. (ATHA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kronos Bio, Inc. (KRON) No price found
COO & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.14% | -10.68K |
$1.18 | -$12,636.11 | 928.97K |
Jan 4
| |||
Form 4
| +17.35% | 138.91K |
—
|
—
| 939.64K |
Feb 15
| |||
Form 4
| +7.26% | 53.6K |
—
|
—
| 791.62K |
Jul 25
| |||
Form 4
| +7.83% | 53.6K |
—
|
—
| 738.02K |
Feb 15
| |||
Form 4
| +11.36% | 69.82K |
—
|
—
| 684.42K |
Dec 9
| |||
Form 4
| +0.86% | 5.25K |
$19.00 | $99,750.00 | 614.6K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Locust Walk Acquisition Corp. (EFTR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||